Google Chrome
Safari
Firefox
Edge
Press Clipping / Sep 23, 2020
Hovione Announces Partnership to Produce Ligand’s Captisol; Used in Gilead’s Covid-19 Treatment
Drug Development & Delivery, September 23, 2020
Search
Press Clipping / May 03, 2023
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Press Release / Jun 08, 2001
FDA inspection to Hovione site in Loures, Portugal - May 31st to June 5th
Press Release / Nov 11, 2021
Hovione invests $170 million in new capacity and capabilities
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
News / Apr 12, 2021
Guy Villax wins EY Award “Entrepreneur of the Year”
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs